There have been early clinical trials of existing ROR gamma inhibitors for autoimmune diseases only. There were no safety problems. The molecules were developed some years ago.
There has been no clinical trial of these for prostate cancer.
The article was about
research of existing ROR gamma inhibitors on mice with prostate cancer.
Trials on humans will depend on drug company commercialization funding and efforts.
Post Edited (RobertC) : 3/30/2016 2:16:31 PM (GMT-6)